Nonalcoholic fatty liver disease (NAFLD), alcohol-induced liver disease (ALD), and viral
hepatitis are the main causes of morbidity and mortality related to chronic liver diseases …

Cannabis and cannabinoids (such as tetrahydrocannabinol and cannabidiol) are frequently
used to relieve gastrointestinal symptoms. Cannabinoids have effects on the immune system …

As perspectives on cannabis continue to shift, understanding the physiological and
behavioral effects of cannabis use is of paramount importance. Previous data suggest that …

Liver steatosis is common in human immunodeficiency virus (HIV)‐hepatitis C virus (HCV)‐
co‐infected patients. Some recent studies have found that cannabis use is negatively …

Cannabis has been used for its medicinal purposes since ancient times. Its consumption
leads to the activation of Cannabis receptors CB1 and CB2 that, through specific …

Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in adults
in developed countries, with a global prevalence as high as one billion. The pathogenesis of …

Chronic hepatitis C virus (HCV) infection is a risk factor of insulin resistance, and HCV‐
infected patients are at a high risk of developing diabetes. In the general population …

Cannabinoids in Liver Diseases Page 1 REVIEW Cannabinoids in Liver Diseases Eleonora
Patsenker, Ph.D.,* and Felix Stickel, MD, Ph.D.*,† Mounting evidence indicates that the …

HIV infection and nonalcoholic fatty liver disease (NAFLD) are two major epidemics affecting
millions of people worldwide. As people with HIV (PWH) age, there is an increased …

Mortality among individuals co-infected with HIV and hepatitis C virus (HCV) is relatively
high. We evaluated the association between psychoactive substance use and both HCV and …